Risk of tuberculosis comparison in new users of antitumour necrosis factor‐α and with existing disease‐modifying antirheumatic drug therapy-Reference-Cited by-同舟云学术

Risk of tuberculosis comparison in new users of antitumour necrosis factor‐α and with existing disease‐modifying antirheumatic drug therapy

Author:

Chan M.‐J.¹,Wen Y.‐H.¹,Huang Y.‐B.¹²,Chuang H.‐Y.³,Tain Y.‐L.⁴,Lily Wang Y.‐C.⁵,Hsu C.‐N.¹⁵

Affiliation:

1. School of Pharmacy Kaohsiung Medical University Kaohsiung Taiwan

2. Department of Pharmacy Kaohsiung Medical University Chung‐Ho Memorial Hospital Kaohsiung Taiwan

3. Department of Public Health Center of Excellence for Environmental Medicine Kaohsiung Medical University Hospital Kaohsiung Taiwan

4. Department of Pediatrics Kaohsiung Chang Gung Memorial Hospital and College of Medicine Chang Gung University Kaohsiung Taiwan

5. Department of Pharmacy Kaohsiung Chang Gung Memorial Hospital Kaohsiung Taiwan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference32 articles.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Clinical experience of TB in patients treated with anti-TNF-α;The International Journal of Tuberculosis and Lung Disease;2021-10-01